Top

--Passive Transfer Study in a Murine Model

Active

W81XWH08001JBFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The United States Army Research Institute of Infectious Diseases (USAMRIID) requires a Passive Transfer Study for the Department of Molecular Virology under the Joint Science and Technology Chemical and Biological Defense Research Program. The study focuses on immunotherapeutics targeting Orthopoxvirus, specifically characterizing human monoclonal antibodies against the vaccinia virus to provide protection against infection. This work continues from an existing contract, ensuring scientific consistency regarding the challenge strain, facilities, and technical procedures. Although the original work was planned for the Southern Research Institute in Birmingham, Alabama, the actual execution will take place at the Frederick location in Maryland due to its specialized capabilities in supporting therapeutic and vaccine efficacy studies involving small and large animal models. The project falls under the North American Industry Classification System code 541380 with a size standard of 500 employees. This opportunity is not a request for competitive quotes, but interested parties must submit written responses demonstrating their qualifications, relevant experience, and past performance to support their capability to perform the study. Responses are to be addressed to the government by August 15, 2008, at 3:00 PM Eastern Standard Time, after which the contract modification will be awarded without further notice if no submissions are received. The Contracting Officer will decide the procurement strategy based on the information provided. The designated point of contact for this action is Ms. Juanita Bourne.

General Info

USAMRIID requires passive transfer study on vaccinia virus antibodies; responses due August 15, 2008.

Agency

N/A

NAICS

541380 - Testing Laboratories and Services

Place of Performance

Not specified

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedJul 31

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyN/A

ContactsNo contacts available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

ContactsNo contact information available

Full Description

The United States Army Research Institute of Infectious Diseases (USAMRIID) has a requirement for a Passive Transfer Study for the Department of Molecular Virology for Joint Science and Technology Chemical and Biological Defense Research Program. The North American Industry Classification System Code applicable to this work is 541380 with a size standard of 500 employees. The Project Plan is for Immunotherapeutic for Orthopoxvirus: characterization of human monoclonal antibodies to vaccinia virus-specific human monoclonal antibodies to protect against infection. This requirement is a follow on work to an existing award in support of USAMRIIDs mission to repeat the passive transfer study in a manner identical to that which was outlined in the existing contract to insure scientific consistency as it pertains to challenge strain, facilities and technical integrity. The proposed work was intended for Southern Research Institute 200 9th Avenue South, Birmingham, Alabama 35205. The work would be accomplished by the Frederick located at 431 Aviation Way, Frederick, Maryland 21701. This was because of their capabilities to support various therapeutic and vaccine efficacy studies for a variety of infectious agents in both small and large animal model systems. This is not a request for a competitive quote. Any response to this notice must be submitted in writing to the Government providing clear and convincing evidence that the contractor is capable of performing the technical requirements and that competition of this and future requirements of this nature would be advantageous to the Government. Your response should include your company qualification, experience, past performance and any other proof of your company's ability to perform this work. All responses will be considered, but the Contracting officer retains the right to determine the procurement strategy, based on available information. If no written responses are received by 3:00 PM Eastern Standard Time on August 15, 2008, the modification to the contract will be awarded without further notice. Please provide your response to contact@example.gov by August 15, 2008. Note 22 are applicable to this announcement. The Point of Contact (POC) for this action is Ms. Juanita Bourne.

Similar Contracts

Same NAICS industry code